Get started
Author

Aigul R. Galembikova

Observed names: A R Galembikova, A. Galembikova, A. R Galembikova, A. R. Galembikova, A.R. Galembikova, Aigul Galembikova, Aygul Galembikova, Galembikova Aigul, А. R. Galembikova, А. Р. Галембикова, Айгуль Рафиковна Галембикова, Галембикова Айгуль Рафиковна
ORCID: 0000-0002-0293-2974
Observed ORCID: 0000-0002-0293-2974
OpenAlex ID: A5009382841
Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance
2017 · Sergei Boichuk, Aigul Galembikova, et al. · Oncology Letters · 54
PDF
A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance
2017 · Sergei Boichuk, Aigul Galembikova, et al. · Molecules · 51
PDF
Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells
2022 · Sergei Boichuk, Pavel Dunaev, et al. · Biomedicines · 38
PDF
The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site
2021 · Sergei Boichuk, Aigul Galembikova, et al. · Molecules · 36
PDF
Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors
2020 · Boichuk Sergei, Dunaev Pavel, et al. · International Journal of Molecular Sciences · 30
PDF
Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo
2018 · Sergei Boichuk, Aigul Galembikova, et al. · Molecules · 30
PDF
Inhibition of AKT-Signaling Sensitizes Soft Tissue Sarcomas (STS) and Gastrointestinal Stromal Tumors (GIST) to Doxorubicin via Targeting of Homology-Mediated DNA Repair
2020 · Sergei Boichuk, Firuza Bikinieva, et al. · International Journal of Molecular Sciences · 26
PDF
Fibroblast Growth Factor 2 (FGF2) Activates Vascular Endothelial Growth Factor (VEGF) Signaling in Gastrointestinal Stromal Tumors (GIST): An Autocrine Mechanism Contributing to Imatinib Mesylate (IM) Resistance
2024 · Sergei Boichuk, Pavel Dunaev, et al. · Cancers · 25
PDF
2-APCAs, the Novel Microtubule Targeting Agents Active against Distinct Cancer Cell Lines
2021 · Sergei Boichuk, Aigul Galembikova, et al. · Molecules · 23
PDF
Inhibition of FGF2-Mediated Signaling in GIST—Promising Approach for Overcoming Resistance to Imatinib
2020 · Sergei Boichuk, Aigul Galembikova, et al. · Cancers · 23
Ethyl-2-amino-pyrrole-3-carboxylates are novel potent anticancer agents that affect tubulin polymerization, induce G2/M cell-cycle arrest, and effectively inhibit soft tissue cancer cell growth in vitro
2016 · Sergei Boichuk, Aigul Galembikova, et al. · Anti-Cancer Drugs · 20
Synthesis and Cytostatic Activity of (E)-Ethyl-2-Amino-5-(3,3-Dimethyl-4-Oxobutyliden)-4-Oxo-1- (2-Phenylaminobenzamido)-4,5-Dihydro-1Hpyrrol-3-Carboxylate
2020 · S. S. Zykova, I. A. Kizimova, et al. · Pharmaceutical Chemistry Journal · 15
Carboxyl-BODIPY based fluorescent biomarkers: Spectral characteristics, photostability and possibilities for practical application
2023 · Galina B. Guseva, Michail M. Lukanov, et al. · Journal of Photochemistry and Photobiology A Chemistry · 13
Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin
2022 · Sergei Boichuk, Kirill Syuzov, et al. · Molecules · 13
PDF
Spectral properties and anticancer activity of novel cisplatin-BODIPY conjugates
2025 · Ksenia V. Ksenofontova, Alexander A. Ksenofontov, et al. · Optical Materials · 12
Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations
2023 · Sergei Boichuk, Pavel Dunaev, et al. · Cancers · 12
PDF
Inhibition of fibroblast growth factor receptor-signaling sensitizes imatinib-resistant gastrointestinal stromal tumors to low doses of topoisomerase II inhibitors
2018 · Sergei Boichuk, Pavel Dunaev, et al. · Anti-Cancer Drugs · 12
Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells
2024 · Vera Dugina, Maria Vasileva, et al. · International Journal of Molecular Sciences · 9
PDF
Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline
2023 · Sergei Boichuk, Firyuza Bikinieva, et al. · Diagnostics · 9
PDF
Synthesis and Biological Activity of 2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1h-pyrrole-3-carboxamides
2018 · S. S. Zykova, N. M. Igidov, et al. · Pharmaceutical Chemistry Journal · 9
Unraveling the Mechanism of Platelet Aggregation Suppression by Monoterpenoids
2022 · Liliya E. Nikitina, Roman S. Pavelyev, et al. · Bioengineering · 8
PDF
Ethyl-2-amino-pyrrole-3-carboxylates are active against imatinib-resistant gastrointestinal stromal tumors in vitro and in vivo
2019 · Sergei Boichuk, Aigul Galembikova, et al. · Anti-Cancer Drugs · 7
Synthesis and Cytotoxic Activity of Ethyl 2-Amino-1-Benzamido-4-Oxo-5-(2-Oxo-2-Arylethylidene)- 4,5-Dihydro-1H-Pyrrole-3-Carboxylates
2016 · S. S. Zykova, A. R. Galembikova, et al. · Pharmaceutical Chemistry Journal · 6
Enhancement of NK Cell Cytotoxic Activity and Immunoregulatory Effects of a Natural Product Supplement Across a Wide Age Span: A 30-Day In Vivo Human Study
2025 · Sergei Boichuk, Aigul Galembikova, et al. · International Journal of Molecular Sciences · 5
Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
2015 · S. V. Boichuk, A. R. Galembikova, et al. · Advances in molecular oncology · 5
PDF
Works count: 61
Citation count: 534
H-index: 13
I10-index: 17
Year
Topic
Type